It follows the same regulatory arc as BPC-157 and TB-500: Category 2 placement in 2023, removal from Category 2 in April 2026, and formal PCAC review scheduled for July 23, 2026
Additionally, it shows a greater ability to inhibit tyrosinase activity (an enzyme that produces melanin and causes hyperpigmentation) than other antioxidants used in skin care, such as kojic acid 2
In a clinical environment, safety protocols are non-negotiable
Erythrocyte catalase activity Erythrocyte catalase (e-CAT) activity was determined with a spectrophotometric assay at 240 nm (25 C)
Let me know how I can help improve your quality of life and help you feel your best
Submitting without a diagnosis code, or substituting an influenza illness code, results in a denial